GENOPLAN INC. — Form D

GENOPLAN INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-03-21. The offering totals $5.0M, of which $4.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2016-03-21
• Form: D
• Accession: 0001015325-16-000043
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $5.0M
• Amount sold: $4.2M
• Remaining: $800K
• Investors: 4
• Date of first sale: 2016-03-14
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-259639

Issuer

• Name: GENOPLAN INC.
• CIK: 0001669736
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: C/O WEWORK, NEW YORK, NY, 10018
• Phone: (317) 829-4522

Officers, directors & promoters (3)

More

• CIK 1669736 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search